|Articles|January 17, 2017
Renova Therapeutics Selects Worldwide Clinical Trials
Renova Therapeutics has announced the selection of Worldwide Clinical Trials as its CRO for an upcoming gene therapy study.
Advertisement
Renova Therapeutics has announced the selection of Worldwide Clinical Trials as its CRO for an upcoming gene therapy study. Worldwide Clinical Trials will support the Phase III study of RT-100 AC6 gene transfer for the treatment of patients with reduced ejection fraction heart failure.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AI-Driven Clinical Trial Recruitment and Design
2
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
3
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
4
What Clinical Trials Can Learn from the Gig Economy About Payments
5